As on November 23, 2022, Agenus Inc. (NASDAQ: AGEN) started slowly as it slid -1.32% to $3.00. During the day, the stock rose to $3.07 and sunk to $2.97 before settling in for the price of $3.04 at the close. Taking a more long-term approach, AGEN posted a 52-week range of $1.25-$3.62.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
It was noted that the giant of the Healthcare sector posted annual sales growth of 67.30% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 40.90%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 90.00%. This publicly-traded company’s shares outstanding now amounts to $286.85 million, simultaneously with a float of $244.08 million. The organization now has a market capitalization sitting at $879.99 million. At the time of writing, stock’s 50-day Moving Average stood at $2.52, while the 200-day Moving Average is $2.39.
Agenus Inc. (AGEN) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Agenus Inc.’s current insider ownership accounts for 9.64%, in contrast to 59.60% institutional ownership. According to the most recent insider trade that took place on Jan 06, this organization’s Chief Medical Officer sold 38,679 shares at the rate of 3.06, making the entire transaction reach 118,346 in total value, affecting insider ownership by 61,321.
Agenus Inc. (AGEN) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 6/29/2022, the company posted -$0.17 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.23) by $0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
Agenus Inc.’s EPS increase for this current 12-month fiscal period is 90.00% and is forecasted to reach -0.70 in the upcoming year.
Agenus Inc. (NASDAQ: AGEN) Trading Performance Indicators
Let’s observe the current performance indicators for Agenus Inc. (AGEN). It’s Quick Ratio in the last reported quarter now stands at 1.50. The Stock has managed to achieve an average true range (ATR) of 0.22. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 9.79.
In the same vein, AGEN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.80, a figure that is expected to reach -0.21 in the next quarter, and analysts are predicting that it will be -0.70 at the market close of one year from today.
Technical Analysis of Agenus Inc. (AGEN)
Through scrutinizing the latest numbers posted by the [Agenus Inc., AGEN], it can be observed that its last 5-days Average volume of 4.04 million was lower the volume of 4.62 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 69.37% While, its Average True Range was 0.23.